Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-27

FDA Approved: RISPERIDONE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved Chartwell RX, LLC's generic risperidone through an ANDA, authorizing the generic product for the same indications as the brand.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)